Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Big Technologies suspends CEO amid litigation

(Sharecast News) - Big Technologies announced the suspension of its chief executive officer Sara Murray on Tuesday, following concerns about her conduct related to ongoing litigation. The AIM-traded remote monitoring technology company cited recent revelations that prompted further internal investigations.

It said the probe would be led by interim chairman Alexander Brennan.

The litigation in question stemmed from a claim filed in 2023 with the High Court of Justice of England and Wales.

It said the case, brought by former shareholders of Buddi Limited, a subsidiary of Big Technologies, related to its 2018 acquisition.

The company said it was continuing to review its legal position and woul provide updates as necessary.

During Murray's suspension, chief financial officer Daren Morris would assume the role of interim CEO, while chief operating officer Charles Lewinton would support him to maintain operational stability.

Despite the leadership turmoil, Big Technologies reported a strong start to the financial year, with performance aligning with market expectations.

As of February, the company held more than £100m in cash reserves.

Analysts forecast 2024 revenue between £50m and £50.2m, with a consensus of £50.1m, and adjusted EBITDA ranging from £26m to £27.1m, with a consensus of £26.7m.

The company said it was optimistic about its growth trajectory, expecting revenue expansion in 2025, aided by favourable conditions in the electronic monitoring market.

Reporting by Josh White for Sharecast.com

Share this article

Related Sharecast Articles

Chesnara's £260m purchase of HSBC Life UK clears regulatory hurdle
(Sharecast News) - Life and pension consolidator Chesnara has received regulatory approval for its £260m acquisition of HSBC's UK life insurance manufacturing business.
GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Orosur nears completion of Pepas drilling
(Sharecast News) - Orosur Mining said drilling at its Pepas gold prospect in Colombia was nearing completion as the company moves toward an initial NI43-101 compliant mineral resource estimate, while first drill holes at its El Pantano project in Argentina have confirmed the presence of a previously undrilled mineral system.
Botswana Diamonds reports progress in 'difficult year' for industry
(Sharecast News) - Botswana Diamonds reported progress across its exploration portfolio for the year ended 30 June despite what it described as a "very difficult year for the diamond industry", as the AIM-listed company diversified into critical minerals and expanded the use of artificial intelligence in its exploration strategy.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.